1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influence of in vivo Hsp90α inhibition on irisin signaling to the brain

      abstract

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Irisin is an exercise‐induced myokine that elicits beneficial effects of exercise in fat, bone, and the brain. Previous work suggests that extracellular heat shock protein 90a (Hsp90a) mediates irisin‐receptor interaction in bone and fat. Despite this, it remains unclear if Hsp90a is necessary for irisin signaling in the brain.

          Methods

          Female F344 rats (3‐4 mo, n = 32) were randomized into four treatment groups: irisin + Hsp90a inhibition (IX, n = 10); irisin + vehicle o.g. (IC, n = 10); vehicle i.p. + Hsp90a inhibition (CX, n = 6) and; vehicle i.p. + vehicle o.g. (CC, n = 6). Due to the impact of irisin on memory, a novel object recognition test was conducted over 4 days. Days 1‐2 were habituation, day 3 was familiarization, and day 4 was testing. Directly following NOR day 2, animals received single administrations of irisin (100 mg/kg, i.p.) or vehicle control and selective Hsp90a inhibitor SNX‐5422 (10 mg/kg, o.g.) or vehicle control. Day 4 NOR testing and tissue collection occurred 48 hours following drug administrations. Blood was collected via LV puncture, centrifuged to isolate serum, and stored at ‐80°C. Brains were sectioned, weighed, and snap‐frozen in liquid nitrogen. The downstream target of irisin signaling, hippocampal cyclic‐AMP Response Element Binding Protein (CREB) was quantified via Jess Simple Western automated western blot analysis. Hippocampal BDNF and serum irisin were quantified via ELISA. Values are mean ± standard deviation.

          Results

          In the NOR task, the IC group displayed a preference for the novel object (68.77 ± 17.93% of exploration time with novel object; p<0.01, one‐sample t‐test vs 50%). Novel object preference was not displayed in other groups. Hippocampal total CREB was greater in the IC than in the CC group (11.0 ± 0.85 vs 9.4 ± 0.80 a.u.; p<0.05, one‐way ANOVA). No differences in tissue masses, levels of hippocampal phosphorylated CREB, p/t CREB, and BDNF or serum irisin were present between groups 48 hours following dosing.

          Conclusions

          This investigation supports irisin signaling to promote memory function and indicates a mediating role of Hsp90a in the brain. Further analysis of hippocampal mRNA is needed to understand the influence of Hsp90a inhibition on irisin‐mediated transcriptional changes.

          Related collections

          Author and article information

          Contributors
          zjwhite@ksu.edu
          Journal
          Alzheimers Dement
          Alzheimers Dement
          10.1002/(ISSN)1552-5279
          ALZ
          Alzheimer's & Dementia
          John Wiley and Sons Inc. (Hoboken )
          1552-5260
          1552-5279
          09 January 2025
          December 2024
          : 20
          : Suppl 6 ( doiID: 10.1002/alz.v20.S6 )
          : e091959
          Affiliations
          [ 1 ] Kansas State University, Manhattan, KS USA
          Author notes
          [*] [* ] Correspondence

          Zachary J White, Kansas State University, Manhattan, KS, USA.

          Email: zjwhite@ 123456ksu.edu

          Article
          ALZ091959
          10.1002/alz.091959
          11713233
          30172dee-b57a-4496-b296-6fe968728d17
          © 2024 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

          This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

          History
          Page count
          Figures: 0, Tables: 0, Pages: 2, Words: 479
          Categories
          Drug Development
          Drug Development
          Poster Presentation
          Nonhuman
          Custom metadata
          2.0
          December 2024
          Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.2 mode:remove_FC converted:09.01.2025

          Comments

          Comment on this article